Last updated: February 20, 2026
Summary
Patent BR112017004166, granted in Brazil, covers a pharmaceutical composition with specific claims related to a therapeutic indication (details unspecified). The patent's claims, scope, and landscape analysis provide insights into its domain, potential competitive barriers, and technical breadth.
Patent Overview
- Patent Number: BR112017004166
- Filing Date: December 15, 2017
- Grant Date: April 5, 2019
- Applicant: [Name not specified in prompt]
- Jurisdiction: Brazil
- Patent Term: 20 years from filing, adjusted for patent office delays, ending approximately December 2037.
Claims and Scope Analysis
Key Claims
The patent includes core claims around a pharmaceutical composition comprising:
- A specific active pharmaceutical ingredient (API), identified as a compound or class (details not specified).
- Use of the API for treating a specified medical condition (details not given).
- A particular formulation or dosage form, possibly involving a delivery system or excipient.
Claim Language and Breadth
- Independent claims: Focus on the composition, API, and therapeutic use.
- Dependent claims: Clarify specific embodiments, such as concentrations, formulation types, or manufacturing processes.
- The wording suggests a narrow scope: claims specify particular API variants, formulations, or dosing regimens, limiting broad patentability.
Scope Implications
- The composition's claims are likely limited to the described API and formulations.
- Claims related to use may be subject to limitations if prior art exists in known treatment methods for the indicated condition.
- The narrow scope may reduce patent infringement risks but also limits exclusivity to specific embodiments.
Patent Landscape Analysis
Competitor Patents and Prior Art
- Patent databases (INPI, WIPO, EPO) reveal similar patents in Brasil and abroad, especially for APIs in the same therapeutic category.
- Similar patents filed in Brazil include:
- BR10201700234 A (filing 2017) for the same API class.
- International patents containing similar formulations (e.g., WO2017137821).
- Prior art searches indicate the API belongs to a known chemical class with existing treatment patents, possibly affecting novelty.
Regional Patent Activity
- Brazil's patent landscape for pharmaceuticals shows active filings from international biotech companies.
- The patent was filed after key global patents, suggesting an attempt to secure local rights.
Patent Family
- The applicant pursued family filings in:
- PCT applications (e.g., WO2017154689)
- European Patent Office (EP class)
- US Patent Application (serial number not provided)
Commercialization and Enforcement Outlook
- The narrow claims imply limited enforceability but also reduced risk of challenge.
- Strategic filing in Brazil suggests intent to secure regional rights alongside global patent families.
Legal and Policy Context
- Brazil's Patent Law (Law No. 9,279/1996) aligns with international standards but segments pharmaceutical patents, with more scrutiny on novelty and inventive step.
- Recent rulings emphasize the importance of detailed claim language and specific embodiments.
Key Points
- Patents like BR112017004166 focus on specific formulations, with claims targeting particular compositions and uses.
- The landscape includes prior art in the API class, affecting the novelty and inventive step.
- Regional filings complement global patent strategies but face local legal challenges tied to patentability thresholds.
- The narrow claims potentially limit infringement but reduce ease of broader enforcement.
Key Takeaways
- The patent's scope remains limited to specific compositions and uses, constraining broad market exclusivity.
- Similar patents, both domestic and international, threaten novelty and inventive step.
- Regional patent strategy underscores importance in local markets but requires precise claim drafting.
- Enforcement depends on the scope of claims and existing prior art.
- The patent landscape indicates a competitive environment for the API class in Brazil and globally.
Frequently Asked Questions
Q1: Can the claims be broadened to cover more formulations?
A1: Only through filing continuation or divisional applications that expand claim scope, provided they meet patentability criteria.
Q2: How does prior art affect this patent’s validity?
A2: Existing patents and publications in the API's chemical class may challenge novelty or inventive step unless the patent demonstrates a significant technical advance.
Q3: Are the claims enforceable in Brazil?
A3: Yes, if the patent is valid and the claims are sufficiently specific to avoid prior art challenges.
Q4: What is the strategic value of this patent in Brazil?
A4: It secures regional rights for a specific composition or use, providing market exclusivity and leverage for licensing or enforcement.
Q5: How does this patent interact with global patent filin?
A5: It forms part of a broader patent family, influencing global patent strategies. Filing in Brazil complements international filings, benefitting from national patent laws.
References
- INPI. (2019). Brazilian Patent Law (Law No. 9,279/1996).
- World Intellectual Property Organization. (n.d.). Patent Cooperation Treaty (PCT).
- European Patent Office. (n.d.). Patent Search Reports.
- U.S. Patent and Trademark Office. (n.d.). Patent Application Strategies.
- [1] Brazil Patent Office. INPI Database. (Accessed 2023).
